2021
DOI: 10.3389/fcimb.2021.586427
|View full text |Cite
|
Sign up to set email alerts
|

Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective

Abstract: Since the 1950s, gradual changes in the gut microbiota of patients with hepatic encephalopathy have been observed. Previous research has indicated potential associations between the gut and brain, and the gut microbiota is becoming a hot topic in research on diseases of the nervous system. However, for the past few decades, studies of hepatic encephalopathy have been restricted to controlling the gut microbiota during macroscopic manipulation, such as probiotic intervention, while its clinical use remains cont… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 95 publications
0
10
0
Order By: Relevance
“…Ruminococcaceae is negatively associated with inflammation and Bacteroides spp. is related to the onset of systemic immune response and the prevention of bacterial translocation. , Moreover, Dorea and Roseburia can be thought to be biomarkers of inflammation and cognition that are associated with acetylcholinesterase inhibitors …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Ruminococcaceae is negatively associated with inflammation and Bacteroides spp. is related to the onset of systemic immune response and the prevention of bacterial translocation. , Moreover, Dorea and Roseburia can be thought to be biomarkers of inflammation and cognition that are associated with acetylcholinesterase inhibitors …”
Section: Discussionmentioning
confidence: 99%
“…It is commonly agreed that hyperammonemia is responsible for the pathological, clinical, and neurochemical changes in HE, and ammonia levels are extensively utilized for diagnosing HE patients. Increasing evidence shows that the development of HE is driven by its metabolic by-products and the change in the structure of the gut microbiota, along with a background of leaky gut and local and systemic inflammation . COS has obtained enormous attention due to nontoxic, functional, biodegradable natural, and biological activities for various applications. , Recently, the utilization of COS has demonstrated great potential in health care because it does not show any toxic influence after oral administration to rats at doses ranging from 500 to 2000 mg/kg/day for 28 days .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The temperature required for storage of these microbiota capsules is about -80°C (112°F) for half year (6 months) before use [Figure 2]. [28] Mode of action of FMT…”
Section: Processing Of Fecal Materialsmentioning
confidence: 99%
“…There is ongoing research into the potential use of FMT for other gastrointestinal diseases where disruption of the gut microbiome may be relevant. A recent study looking at FMT in the treatment of hepatic encephalopathy produced some encouraging results (Liu et al., 2021). There is also emerging evidence for use of FMT in Primary Scelrosing Cholangitis.…”
Section: Role Of the Microbiome In Diseasementioning
confidence: 99%